MKT CAP:$51B

Edwards Lifesciences Corp

Market Cap

$51B

Healthcare·Medical Devices·🇺🇸 United States·NYSE

Healthcare·Medical Devices·🇺🇸·NYSE

Stock Price

$85.85+$0.52 (+0.61%)

Jun 8, 2026

52W High $88.1652W Low $72.65

Company Details

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally i...

CEO

—

IPO Date

Mar 27, 2000

Website

www.edwards.com

Key Metrics TTM

Revenue

$6.3B

+13.8% YoY

Net Income

$1.1B

EPS (Diluted)

Free Cash Flow

$1.1B

Revenue / Share

$10.86

Gross Margin

78.0%

Operating Margin

27.6%

Net Margin

17.3%

FCF Margin

17.3%

P/S

8.1x

P/E

46.5x

Earnings Reports

Q2 2026

Jul 23, 2026

PENDING

Q1 2026

May 6, 2026

$1.6B+16.7%

FY 2025

Feb 25, 2026

$6.1B+11.5%

Q4 2025

Feb 25, 2026

$1.6B+13.3%

Q3 2025

Nov 5, 2025

$1.6B+14.7%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee